Yes, but the question still remains, why?
A lot of speculative answers, obfuscation, shorty backed hedgies, MM's etc...
But a cogent reasonable explanation has not been forthcoming..
Curios minds want to know!
fourth Quarter Earnings Announcement Expected: Earnings will tentatively be announced 02/26/2015. With 7 analysts covering SQNM, the consensus EPS estimate is -$0.04, and the high and low estimates are -$0.01 and -$0.07, respectively.
Expected Timing: After close
The date was gathered by Wall Street Horizon callers, but it is still considered tentative.
I agree,with listener no bigee.
I was in upper management for many years.
Sometimes you have to reward the employees, especially if they have worked many years on a shoe string. stock options are a carrot, as no one wants to cash them in when they believe they will be worth much more in the future.
Cash is an instant good will bonus that stops the grumbling and creates loyalty! Wisely management distributed most of it to the lower echelon.
Hopefully and maybe, SQNM has an Ace up their sleeve that justifies this payout.
Will we see this Ace tomorrow?
Didn't see that either. Just a summary, but would like more details.
As discussed previously, the Oncology aspect is the 800 lb gorilla in the room. ;-)
You read it wrong..
Revenue is bottom set of numbers (why they presented cash burn before revenue is wierd)
Cash burn reduced to $37M for 2014
Revenue is 151M. for 2014
Page 23 says revenue of $151M for 2014.
Page 24 is Corporate Goals for 2015.
Are we viewing the same document?
I like my document better
From summary of presentation on their Web Site
Approximately $94M*** in ending cash
Reduced cash burn from $107M* in FY2013 to
$37M* in FY2014
Divested Bioscience business
Seems like they are saying they reduced burn to $37M from $107M, not revenue.
Brean Capital assumed coverage on shares of Horizon Pharma PLC (NASDAQ:HZNP) in a research note issued on Wednesday The firm set a “buy” rating on the stock.